Cited by 87Neuroinflammation and Neurodegeneration MechanismsPhagocytosis and Immune RegulationInflammasome and immune disorders

Microglial Immunoreceptor Tyrosine-Based Activation and Inhibition Motif Signaling in Neuroinflammation

Open access
Linnartz, Bettina, Wang, Yiner, Neumann, Harald·2010·International Journal of Alzheimer's Disease

Abstract

Elimination of extracellular aggregates and apoptotic neural membranes without inflammation is crucial for brain tissue homeostasis. In the mammalian central nervous system, essential molecules in this process are the Fc receptors and the DAP12-associated receptors which both trigger the microglial immunoreceptor tyrosine-based activation motif- (ITAM-) Syk-signaling cascade. Microglial triggering receptor expressed on myeloid cells-2 (TREM2), signal regulatory protein-1, and complement receptor-3 (CD11b/CD18) signal via the adaptor protein DAP12 and activate phagocytic activity of microglia. Microglial ITAM-signaling receptors are counter-regulated by immunoreceptor tyrosine-based inhibition motif- (ITIM-) signaling molecules such as sialic acid-binding immunoglobulin superfamily lectins (Siglecs). Siglecs can suppress the proinflammatory and phagocytic activity of microglia via ITIM signaling. Moreover, microglial neurotoxicity is alleviated via interaction of Siglec-11 with sialic acids on the neuronal glycocalyx. Thus, ITAM- and ITIM-signaling receptors modulate microglial phagocytosis and cytokine expression during neuroinflammatory processes. Their dysfunction could lead to impaired phagocytic clearance and neurodegeneration triggered by chronic inflammation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4061/2010/587463

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 51

  1. [1]Biber K Neumann H Inoue K Boddeke HWGM Neuronal ’On’ and ’Off’ signals control microglia Trends in Neurosciences 2007 30 11 596 602 17950926
  2. [2]Hanisch U-K Kettenmann H Microglia: active sensor and versatile effector cells in the normal and pathologic brain Nature Neuroscience 2007 10 11 1387 1394 17965659
  3. [4]Aloisi F Immune function of microglia GLIA 2001 36 2 165 179 11596125
  4. [5]Carson MJ Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis GLIA 2002 40 2 218 231 12379909 PMC2693029
  5. [7]Neumann H Kotter MR Franklin RJM Debris clearance by microglia: an essential link between degeneration and regeneration Brain 2009 132 2 288 295 18567623 PMC2640215
  6. [9]Hu S Chao CC Ehrlich LC Inhibition of microglial cell RANTES production by IL-10 and TGF-β Journal of Leukocyte Biology 1999 65 6 815 821 10380904
  7. [10]Mrak RE Griffin WST Glia and their cytokines in progression of neurodegeneration Neurobiology of Aging 2005 26 3 349 354 15639313
  8. [15]Liu Y Walter S Stagi M LPS receptor (CD14): a receptor for phagocytosis of Alzheimer’s amyloid peptide Brain 2005 128 8 1778 1789 15857927
  9. [16]Reed-Geaghan EG Savage JC Hise AG Landreth GE CD14 and toll-like receptors 2 and 4 are required for fibrillar Aβ-stimulated microglial activation Journal of Neuroscience 2009 29 38 11982 11992 19776284 PMC2778845
  10. [17]Kielian T Toll-like receptors in central nervous system glial inflammation and homeostasis Journal of Neuroscience Research 2006 83 5 711 730 16541438 PMC2440498
  11. [19]Hamerman JA Ni M Killebrew JR Chu C-L Lowell CA The expanding roles of ITAM adapters FcRγ and DAP12 in myeloid cells Immunological Reviews 2009 232 1 42 58 19909355 PMC3248395
  12. [20]Nimmerjahn F Ravetch JV Fc-receptors as regulators of immunity Advances in Immunology 2007 96 179 204 17981207
  13. [21]Ziegenfuss JS Biswas R Avery MA Draper-dependent glial phagocytic activity is mediated by Src and Syk family kinase signalling Nature 2008 453 7197 935 939 18432193 PMC2493287
  14. [22]Tomasello E Cant C Bhring H-J Association of signal-regulatory proteins β with KARAP/DAP-12 European Journal of Immunology 2000 30 8 2147 2156 10940905
  15. [25]Gaikwad S Larionov S Wang Y Signal regulatory protein-β1: a microglial modulator of phagocytosis in Alzheimer’s disease American Journal of Pathology 2009 175 6 2528 2539 19893026 PMC2789620
  16. [26]N’Diaye E-N Branda CS Branda SS TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria Journal of Cell Biology 2009 184 2 215 223 19171755 PMC2654305
  17. [27]Crocker PR Paulson JC Varki A Siglecs and their roles in the immune system Nature Reviews Immunology 2007 7 4 255 266 17380156
  18. [29]Angata T Kerr SC Greaves DR Varki NM Crocker PR Varki A Cloning and characterization of human Siglec-11: a recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia Journal of Biological Chemistry 2002 277 27 24466 24474 11986327
  19. [30]Ravetch JV Bolland S IgG Fc receptors Annual Review of Immunology 2001 19 275 290 11244038
  20. [31]Nimmerjahn F Ravetch JV Fcγ receptors: old friends and new family members Immunity 2006 24 1 19 28 16413920
  21. [32]Stephens L Ellson C Hawkins P Roles of PI3Ks in leukocyte chemotaxis and phagocytosis Current Opinion in Cell Biology 2002 14 2 203 213 11891120
  22. [33]García-García E Rosales C Signal transduction during Fc receptor-mediated phagocytosis Journal of Leukocyte Biology 2002 72 6 1092 1108 12488490
  23. [34]Ulvestad E Williams K Vedeler C Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG Journal of the Neurological Sciences 1994 121 2 125 131 8158203
  24. [35]Peress NS Siegelman J Fleit HB Fanger MW Perillo E Monoclonal antibodies identify three IgG Fc receptors in normal human central nervous system Clinical Immunology and Immunopathology 1989 53 2 I 268 280 2477181
  25. [37]Das P Howard V Loosbrock N Dickson D Murphy MP Golde TE Amyloid-β immunization effectively reduces amyloid deposition in FcRγ −/− knock-out mice Journal of Neuroscience 2003 23 24 8532 8538 13679422 PMC6740360
  26. [39]Mócsai A Abram CL Jakus Z Hu Y Lanier LL Lowell CA Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs Nature Immunology 2006 7 12 1326 1333 17086186 PMC4698344
  27. [40]Cao H Lakner U de Bono B Traherne JA Trowsdale J Barrow AD SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans European Journal of Immunology 2008 38 8 2303 2315 18629938
  28. [42]Frank S Burbach GJ Bonin M TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice GLIA 2008 56 13 1438 1447 18551625
  29. [44]Chouery E Delague V Bergougnoux A Koussa S Serre JL Megarbane A Mutations in TREM2 lead to pure early-onset dementia without bone cysts Human Mutation 2008 29 9 E194 E204 18546367
  30. [46]Lanier LL Bakker ABH The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function Immunology Today 2000 21 12 611 614 11114420
  31. [47]Bouchon A Hernández-Munain C Cella M Colonna M A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells Journal of Experimental Medicine 2001 194 8 1111 1122 11602640 PMC2193511
  32. [48]Lu J Wu X Teh BK The regulatory roles of C1q Immunobiology 2007 212 4-5 245 252 17544810
  33. [49]Lauvrak V Brekke OH Ihle Ø Lindqvist BH Identification and characterisation of C1q-binding phage displayed peptides Biological Chemistry 1997 378 12 1509 1519 9461350
  34. [50]Wakselman S Béchade C Roumier A Bernard D Triller A Bessis A Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor Journal of Neuroscience 2008 28 32 8138 8143 18685038 PMC6670768
  35. [51]Maier M Peng Y Jiang L Seabrook TJ Carroll MC Lemere CA Complement C3 deficiency leads to accelerated amyloid β plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice Journal of Neuroscience 2008 28 25 6333 6341 18562603 PMC3329761
  36. [52]Lucin KM Wyss-Coray T Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 2009 64 1 110 122 19840553 PMC2834890
  37. [53]Reichwald J Danner S Wiederhold K-H Staufenbiel M Expression of complement system components during aging and amyloid deposition in APP transgenic mice Journal of Neuroinflammation 2009 6 Article ID 35. PMC2784442 19917141
  38. [54]Eikelenboom P Hack CE Rozemuller JM Stam FC Complement activation in amyloid plaques in Alzheimer’s dementia Virchows Archiv Abteilung B Cell Pathology 1989 56 4 259 262 2565620
  39. [56]Webster S Lue L-F Brachova L Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer’s disease Neurobiology of Aging 1997 18 4 415 421 9330973
  40. [57]Wyss-Coray T Yan F Lin AH-T Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer’s mice Proceedings of the National Academy of Sciences of the United States of America 2002 99 16 10837 10842 12119423 PMC125059
  41. [58]Varki A Angata T Siglecs—the major subfamily of I-type lectins Glycobiology 2006 16 1 16014749
  42. [59]Cao H De Bono B Belov K Wong ES Trowsdale J Barrow AD Comparative genomics indicates the mammalian CD33rSiglec locus evolved by an ancient large-scale inverse duplication and suggests all Siglecs share a common ancestral region Immunogenetics 2009 61 5 401 417 19337729
  43. [60]Angata T Hayakawa T Yamanaka M Varki A Nakamura M Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates FASEB Journal 2006 20 12 1964 1973 17012248
  44. [61]Angata T Tabuchi Y Nakamura K Nakamura M Siglec-15: an immune system Siglec conserved throughout vertebrate evolution Glycobiology 2007 17 8 838 846 17483134
  45. [62]Varki A Natural ligands for CD33-related Siglecs? Glycobiology 2009 19 8 810 812 19429924 PMC2704899
  46. [63]Crocker PR Siglecs in innate immunity Current Opinion in Pharmacology 2005 5 4 431 437 15955740
  47. [65]Zhao J Brooks DM Lurie DI Lipopolysaccharide-activated SHP-1-deficient motheaten microglia release increased nitric oxide, TNF-α, and IL-1β GLIA 2006 53 3 304 312 16265671
  48. [66]Wang Y Neumann H Alleviation of neurotoxicity by microglial human Siglec-11 Journal of Neuroscience 2010 30 9 3482 3488 20203208 PMC6634112
  49. [67]Nutku E Aizawa H Hudson SA Bochner BS Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis Blood 2003 101 12 5014 5020 12609831
  50. [68]Von Gunten S Yousefi S Seitz M Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment Blood 2005 106 4 1423 1431 15827126
  51. [69]Lajaunias F Dayer J-M Chizzolini C Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling European Journal of Immunology 2005 35 1 243 251 15597323

Cited by

Sorted by citations

Authors
Linnartz, B., Wang, Y., & Neumann, H.
Affiliations
  • Neural Regeneration, Institute of Reconstructive Neurobiology, University Hospital Bonn, University Bonn, 53127 Bonn, Germany
  • University of Bonn (DE)
Corresponding author
Neumann, Harald
Venue
International Journal of Alzheimer's Disease
Published
2010
Volume
2010
Pages
1-7
ISSN
2090-0252 (ISSN-L)
OpenAlex
W2071805913
Cited by
87
References
18
Citations by year
2025: 3 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 4 · 2020: 11 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 8
FWCI
3.54
Type
journal article
Language
en
Open access
Locations
  • International Journal of Alzheimer s Disease (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Deutsche Forschungsgemeinschaft (KFO177, SFB 704, DFG‐SFB704, DFG-FOR1336, FOR1336, DFG KFO177)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
microglia, neuroinflammation, ITAM signaling, DAP12, Syk signaling, TREM2, Siglecs, sialic acid, phagocytosis, Fc receptors, CD11b/CD18, neurodegeneration, cytokine expression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review